More than 90% of GLP-1 prescriptions could be filled at lower cost, analysis finds

A $10.2 million savings across more than 100,000 prescriptions over three months, extrapolated across the nearly 33 million Americans currently taking GLP-1 medications monthly, indicates a potential cost savings that is easily in the billions of dollars, the company said.